Junping Kou

6.2k total citations
175 papers, 5.2k citations indexed

About

Junping Kou is a scholar working on Molecular Biology, Complementary and alternative medicine and Epidemiology. According to data from OpenAlex, Junping Kou has authored 175 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Molecular Biology, 28 papers in Complementary and alternative medicine and 27 papers in Epidemiology. Recurrent topics in Junping Kou's work include Natural product bioactivities and synthesis (27 papers), Phytochemical Studies and Bioactivities (26 papers) and Traditional Chinese Medicine Analysis (20 papers). Junping Kou is often cited by papers focused on Natural product bioactivities and synthesis (27 papers), Phytochemical Studies and Bioactivities (26 papers) and Traditional Chinese Medicine Analysis (20 papers). Junping Kou collaborates with scholars based in China, United States and Macao. Junping Kou's co-authors include Boyang Yu, Fang Li, Fang Huang, Yuanyuan Zhang, Baolin Liu, Guosheng Cao, Yuanyuan Zhang, Danni Zhu, Qian Liu and Sulan Yu and has published in prestigious journals such as Stroke, Scientific Reports and The FASEB Journal.

In The Last Decade

Junping Kou

170 papers receiving 5.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junping Kou China 40 2.9k 651 634 582 551 175 5.2k
Xiaobo Sun China 42 3.1k 1.1× 696 1.1× 681 1.1× 419 0.7× 612 1.1× 178 5.5k
Guibo Sun China 51 3.6k 1.3× 964 1.5× 866 1.4× 502 0.9× 793 1.4× 211 6.7k
Chao Guo China 38 2.4k 0.8× 648 1.0× 354 0.6× 634 1.1× 440 0.8× 162 4.6k
Joen‐Rong Sheu Taiwan 43 2.1k 0.7× 846 1.3× 342 0.5× 442 0.8× 624 1.1× 233 6.0k
Yunman Li China 39 1.8k 0.6× 576 0.9× 361 0.6× 1.0k 1.7× 382 0.7× 157 4.1k
Cheol Park South Korea 44 3.2k 1.1× 509 0.8× 396 0.6× 359 0.6× 566 1.0× 259 6.5k
Ki Churl Chang South Korea 47 3.0k 1.0× 513 0.8× 532 0.8× 297 0.5× 709 1.3× 169 6.5k
Qihai Gong China 44 2.1k 0.7× 548 0.8× 309 0.5× 778 1.3× 884 1.6× 149 4.9k
Lina Xu China 48 3.3k 1.2× 399 0.6× 876 1.4× 249 0.4× 845 1.5× 162 6.2k
Jae‐Young Um South Korea 45 3.5k 1.2× 867 1.3× 781 1.2× 311 0.5× 842 1.5× 263 7.5k

Countries citing papers authored by Junping Kou

Since Specialization
Citations

This map shows the geographic impact of Junping Kou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junping Kou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junping Kou more than expected).

Fields of papers citing papers by Junping Kou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junping Kou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junping Kou. The network helps show where Junping Kou may publish in the future.

Co-authorship network of co-authors of Junping Kou

This figure shows the co-authorship network connecting the top 25 collaborators of Junping Kou. A scholar is included among the top collaborators of Junping Kou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junping Kou. Junping Kou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Yuan, et al.. (2025). The role of ROCK1/MLC/NMMHC IIA-actin signaling in ischemic stroke-induced blood-brain barrier disruption: implications for therapeutic intervention. Cellular and Molecular Life Sciences. 82(1). 373–373. 1 indexed citations
2.
Liu, Jincheng, Qing‐Fei Zhao, Ling Zhang, et al.. (2023). Ruscogenin Alleviates Myocardial Ischemia via Myosin IIA-Dependent Mitochondrial Fusion and Fission Balance. The American Journal of Chinese Medicine. 51(7). 1879–1904. 2 indexed citations
3.
Yu, Boyang, Daojun Hong, Teng Guan, et al.. (2023). Background and roles: myosin in autoimmune diseases. Frontiers in Cell and Developmental Biology. 11. 1220672–1220672. 2 indexed citations
4.
Huang, Juan, Jian-Hao Zhou, Yujie Dai, et al.. (2023). Ruscogenin ameliorates dasatinib-induced intestinal barrier dysfunction via ErbB4/YAP and ROCK/MLC pathways. Journal of Natural Medicines. 77(4). 735–747. 3 indexed citations
5.
Fu, Fei, Qiong Lai, Lu Zhang, et al.. (2022). Ruscogenin Alleviates Myocardial Ischemia-Induced Ferroptosis through the Activation of BCAT1/BCAT2. Antioxidants. 11(3). 583–583. 30 indexed citations
6.
Gong, Shuaishuai, Guosheng Cao, Fang Li, et al.. (2021). Endothelial Conditional Knockdown of NMMHC IIA (Nonmuscle Myosin Heavy Chain IIA) Attenuates Blood-Brain Barrier Damage During Ischemia-Reperfusion Injury. Stroke. 52(3). 1053–1064. 33 indexed citations
7.
Gong, Shuaishuai, Jincheng Liu, Weiwei Yang, et al.. (2021). Schisandrol A Attenuates Myocardial Ischemia/Reperfusion‐Induced Myocardial Apoptosis through Upregulation of 14‐3‐3θ. Oxidative Medicine and Cellular Longevity. 2021(1). 5541753–5541753. 15 indexed citations
8.
Wu, Yunhao, Xiu Yu, Yuwei Wang, et al.. (2021). Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling. Acta Pharmaceutica Sinica B. 12(3). 1198–1212. 42 indexed citations
9.
Wang, Guangyun, et al.. (2019). Schizandrin Protects against OGD/R-Induced Neuronal Injury by Suppressing Autophagy: Involvement of the AMPK/mTOR Pathway. Molecules. 24(19). 3624–3624. 66 indexed citations
10.
Zhang, Yuanyuan, et al.. (2019). Walnut protein isolates attenuate particulate matter-induced lung and cardiac injury in mice and zebra fish. RSC Advances. 9(69). 40736–40744. 10 indexed citations
11.
Yang, Xiaolin, et al.. (2019). Akebia Saponin D Regulates the Metabolome and Intestinal Microbiota in High Fat Diet-Induced Hyperlipidemic Rats. Molecules. 24(7). 1268–1268. 31 indexed citations
12.
Yang, Ye, Yushan Tian, Su‐Xia Li, et al.. (2017). Extract of Sheng-Mai-San Ameliorates Myocardial Ischemia-Induced Heart Failure by Modulating Ca2+-Calcineurin-Mediated Drp1 Signaling Pathways. International Journal of Molecular Sciences. 18(9). 1825–1825. 35 indexed citations
13.
Kou, Junping, et al.. (2016). Advances in the mechanism research of natural products against acute lung injury. 47(4). 397–403. 1 indexed citations
14.
Cao, Guosheng, Yuwei Han, Yang Hu, et al.. (2016). YiQiFuMai Powder Injection Ameliorates Cerebral Ischemia by Inhibiting Endoplasmic Reticulum Stress‐Mediated Neuronal Apoptosis. Oxidative Medicine and Cellular Longevity. 2016(1). 5493279–5493279. 23 indexed citations
15.
Chen, Gangling, Xinyi Ye, Jiangwei Zhang, et al.. (2016). Limb Remote Ischemic Postconditioning Reduces Ischemia-Reperfusion Injury by Inhibiting NADPH Oxidase Activation and MyD88-TRAF6-P38MAP-Kinase Pathway of Neutrophils. International Journal of Molecular Sciences. 17(12). 1971–1971. 46 indexed citations
16.
Chai, Chengzhi, et al.. (2016). Protective Effects of Sheng‐Mai‐San on Right Ventricular Dysfunction during Chronic Intermittent Hypoxia in Mice. Evidence-based Complementary and Alternative Medicine. 2016(1). 4682786–4682786. 8 indexed citations
17.
Li, Hongshi, Li‐An Wu, Liang Xia, et al.. (2014). Danggui-shaoyao-san, a traditional Chinese medicine prescription, alleviates the orthodontic pain and inhibits neuronal and microglia activation. Chinese Medical Journal. 127(20). 3630–3637. 9 indexed citations
18.
Kou, Junping. (2012). Advances on Mechanism Research of Traditional Chinese Prescription for the Treatment of Acute Lung Injury. Zhongguo shiyan fangjixue zazhi. 2 indexed citations
19.
Kou, Junping, et al.. (2011). Anti-inflammatory Effects of Aqueous Extract from Radix Liriope muscari and Its Major Active Fraction and Component. Chinese Journal of Natural Medicines. 9(3). 222–226. 34 indexed citations
20.
Kou, Junping, et al.. (2009). Recent advances of NMHC II A in physiological and pathological functions.. Xiandai shengwu yixue jinzhan. 9(20). 3964–3979. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaobo Sun Breakdown of academic impact, for papers by Guibo Sun Breakdown of academic impact, for papers by Chao Guo Breakdown of academic impact, for papers by Joen‐Rong Sheu Breakdown of academic impact, for papers by Yunman Li Breakdown of academic impact, for papers by Cheol Park Breakdown of academic impact, for papers by Ki Churl Chang Breakdown of academic impact, for papers by Qihai Gong Breakdown of academic impact, for papers by Lina Xu Breakdown of academic impact, for papers by Jae‐Young Um
Rankless by CCL
2026